KX-826 users: 0.5% vs 0.9% vs foam
    Technology 8/3/2025

    At a glance
    In this question or advice post, the primary subjects mentioned are
    ๐Ÿ’ง KX-826 (topical) 0.5%
    ๐Ÿ’ง KX-826 (topical) 0.9%
    โ€ข KX-826 (foam) 0.9%
    the tone is ๐Ÿ˜ neutral.

    Other terms

    KX-826 is being discussed for hair loss treatment, with users debating between 0.5% and 0.9% solutions and foam. Some report side effects like headaches, while others see no changes; it blocks androgen receptors without reducing DHT levels.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 300 results

      community Switch from fin to dut and its worse

      in Finasteride/Dutasteride  6 upvotes 2 months ago
      Switching from finasteride to dutasteride can worsen hair loss for some men due to increased testosterone levels. Topical treatments like RU58841 and Pyrilutamide are suggested to counteract these effects, but individual responses vary.

      community Pyrilutamide Phase 3 on its way

      in Treatment  125 upvotes 3 years ago
      Pyrilutamide Phase 3 approved, starting early 2022 with 416 subjects for 24 weeks. Drug potentially better than RU and Breezula, with some users reporting no side effects.

      community KX-826: Long-Term Safety Results are out!

      in Research/Science  161 upvotes 9 months ago
      KX-826 initially improves hair growth but declines after 24 weeks, with mild itching as a side effect. Combining it with minoxidil and finasteride may improve results, but long-term effectiveness is uncertain.

    Related Research

    6 / 136 results